A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium
Open Access
- 1 August 1999
- Vol. 86 (3) , 514-518
- https://doi.org/10.1002/(sici)1097-0142(19990801)86:3<514::aid-cncr21>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.British Journal of Cancer, 1998
- Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma.Journal of Clinical Oncology, 1998
- Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.Journal of Clinical Oncology, 1997
- Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1997
- Paclitaxel in Advanced Urothelial Carcinoma: Its Role in Patients with Renal Insufficiency and as Salvage TherapyJournal of Urology, 1996
- A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urotheliumCancer, 1996
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1992
- Treatment of Advanced Transitional Cell Carcinoma of the Bladder With Continuous-Infusion Gallium NitrateJNCI Journal of the National Cancer Institute, 1991
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.Journal of Clinical Oncology, 1990
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988